Tocilizumab in refractory Caucasian Takayasu's arteritis: a multicenter study of 54 patients and literature review

被引：21

作者：

Prieto-Pena, Diana ^{[4
]}

Bernabeu, Pilar ^{[5
]}

Vela, Paloma ^{[5
]}

Narvaez, Javier ^{[6
]}

Fernandez-Lopez, Jesus C. ^{[7
]}

Freire-Gonzalez, Mercedes ^{[7
]}

Gonzalez-Alvarez, Beatriz ^{[8
]}

Solans-Laque, Roser ^{[9
]}

Callejas Rubio, Jose L. ^{[10
]}

Ortego, Norberto ^{[10
]}

Fernandez-Diaz, Carlos ^{[11
]}

Rubio, Esteban ^{[12
]}

Garcia-Morillo, Salvador ^{[12
]}

Minguez, Mauricio ^{[13
]}

Fernandez-Carballido, Cristina ^{[13
]}

de Miguel, Eugenio ^{[14
]}

Melchor, Sheila ^{[15
]}

Salgado, Eva ^{[16
]}

Bravo, Beatriz ^{[17
]}

Romero-Yuste, Susana ^{[18
]}

Salvatierra, Juan ^{[10
]}

Hidalgo, Cristina ^{[19
]}

Manrique, Sara ^{[20
]}

Romero-Gomez, Carlos ^{[20
]}

Moya, Patricia ^{[21
]}

Alvarez-Rivas, Noelia ^{[22
]}

Mendizabal, Javier ^{[23
]}

Ortiz-Sanjuan, Francisco ^{[24
]}

Perez de Pedro, Ivan ^{[25
]}

Alonso-Valdivielso, Jose L. ^{[26
]}

Perez-Sanchez, Laura ^{[27
]}

Roldan, Rosa ^{[27
]}

Fernandez-Llanio, Nagore ^{[28
]}

Gomez de la Torre, Ricardo ^{[29
]}

Suarez, Silvia ^{[29
]}

Montesa Cabrera, Maria Jesus ^{[8
]}

Delgado Sanchez, Monica ^{[8
]}

Loricera, Javier ^{[4
]}

Atienza-Mateo, Belen ^{[4
]}

Castaneda, Santos ^{[11
,30
]}

Gonzalez-Gay, Miguel A. ^{[1
,2
,3
]}

Blanco, Ricardo ^{[4
]}

机构：

[1] Hosp Univ Marques de Valdecilla, Rheumatol Div, Res Grp Genet Epidemiol & Atherosclerosis Syst Di, IDIVAL, Ave Valdecilla S-N, Santander 39008, Spain

[2] Univ Cantabria, Sch Med, Santander, Spain

[3] Univ Witwatersrand, Fac Hlth Sci, Sch Physiol, Cardiovasc Pathophysiol & Genom Res Unit, Johannesburg, South Africa

[4] Hosp Univ Marques de Valdecilla, Dept Rheumatol, IDIVAL, Res Grp Genet Epidemiol & Atherosclerosis Syst Di, Santander, Spain

[5] Hosp Gen Alicante, Dept Rheumatol, Alicante, Spain

[6] Hosp Bellvitge Princeps Espanya, Dept Rheumatol, Barcelona, Spain

[7] Complejo Hosp Univ A Coruna, Dept Rheumatol, La Coruna, Spain

[8] Hosp Nuestra Senora Candelaria, Dept Rheumatol, Tenerife, Spain

[9] Hosp Valle De Hebron, Dept Internal Med, Barcelona, Spain

[10] Hosp San Cecilio, Autoimmune Dis Unit, Granada, Spain

[11] Hosp Univ Princesa, Dept Rheumatol, IIS Princesa, Madrid, Spain

[12] Hosp Virgen Rocio, Autoimmune Dis Unit, Seville, Spain

[13] Hosp San Juan Alicante, Dept Rheumatol, Alicante, Spain

[14] Hosp Univ La Paz, Dept Rheumatol, Madrid, Spain

[15] Hosp Univ 12 Octubre, Dept Rheumatol, Madrid, Spain

[16] Complejo Hosp Univ Ourense, Dept Rheumatol, Orense, Spain

[17] Hosp Virgen Nieves, Dept Rheumatol, Granada, Spain

[18] Complejo Hosp Univ Pontevedra, Dept Rheumatol, Pontevedra, Spain

[19] Complejo Univ Salamanca, Dept Rheumatol, Salamanca, Spain

[20] Hosp Reg Malaga, Autoimmune Dis Unit, Malaga, Spain

[21] Hosp Santa Creu & Sant Pau, Dept Rheumatol, Barcelona, Spain

[22] Hosp Univ San Agustin, Dept Rheumatol, Aviles, Spain

[23] Complejo Hosp Navarra, Dept Rheumatol, Pamplona, Spain

[24] Hosp Univ & Politecn La Fe, Dept Rheumatol, Valencia, Spain

[25] Hosp Carlos Haya, Autoimmune Dis Unit, Malaga, Spain

[26] Hosp Univ Burgos, Dept Rheumatol, Burgos, Spain

[27] Hosp Univ Reina Sofia, Dept Rheumatol, Cordoba, Spain

[28] Hosp Arnau Vilanova, Dept Rheumatol, Valencia, Spain

[29] Hosp Univ Cent Asturias, Autoimmune Dis Unit, Oviedo, Spain

[30] Univ Autonoma Madrid IUAMI, UAM ROCHE, EPID Future, Madrid, Spain

来源：

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE | 2021年 / 13卷

关键词：

biological therapy; Caucasian; cDMARDs; Takayasu's arteritis; Tocilizumab; DISEASE-ACTIVITY; EPIDEMIOLOGY; EFFICACY; FEATURES; CRITERIA; OUTCOMES; SAFETY; JAPAN;

D O I：

10.1177/1759720X211020917

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective: To assess the efficacy and safety of tocilizumab (TCZ) in Caucasian patients with refractory Takayasu's arteritis (TAK) in clinical practice. Methods: A multicenter study of Caucasian patients with refractory TAK who received TCZ. The outcome variables were remission, glucocorticoid-sparing effect, improvement in imaging techniques, and adverse events. A comparative study between patients who received TCZ as monotherapy (TCZ(MONO)) and combined with conventional disease modifying anti-rheumatic drugs (cDMARDs) (TCZ(COMBO)) was performed. Results: The study comprised 54 patients (46 women/8 men) with a median [interquartile range (IQR)] age of 42.0 (32.5-50.5) years. TCZ was started after a median (IQR) of 12.0 (3.0-31.5) months since TAK diagnosis. Remission was achieved in 12/54 (22.2%), 19/49 (38.8%), 23/44 (52.3%), and 27/36 (75%) patients at 1, 3, 6, and 12 months, respectively. The prednisone dose was reduced from 30.0 mg/day (12.5-50.0) to 5.0 (0.0-5.6) mg/day at 12 months. An improvement in imaging findings was reported in 28 (73.7%) patients after a median (IQR) of 9.0 (6.0-14.0) months. Twenty-three (42.6%) patients were on TCZ(MONO) and 31 (57.4%) on TCZ(COMBO): MTX (n = 28), cyclosporine A (n = 2), azathioprine (n = 1). Patients on TCZ(COMBO) were younger [38.0 (27.0-46.0) versus 45.0 (38.0-57.0)] years; difference (diff) [95% confidence interval (CI) = -7.0 (-17.9, -0.56] with a trend to longer TAK duration [21.0 (6.0-38.0) versus 6.0 (1.0-23.0)] months; diff 95% CI = 15 (-8.9, 35.5), and higher c-reactive protein [2.4 (0.7-5.6) versus 1.3 (0.3-3.3)] mg/dl; diff 95% CI = 1.1 (-0.26, 2.99). Despite these differences, similar outcomes were observed in both groups (log rank p = 0.862). Relevant adverse events were reported in six (11.1%) patients, but only three developed severe events that required TCZ withdrawal. Conclusion: TCZ in monotherapy, or combined with cDMARDs, is effective and safe in patients with refractory TAK of Caucasian origin.

引用

页数：12

共 50 条

[41] A multicentre, large-scale, observational study of tocilizumab in patients with Takayasu arteritis in Japan: The ACTEMRA® (ACT)-Bridge study [J].

Harigai, Masayoshi ;

Miyamae, Takako ;

Hashimoto, Hideyuki ;

Yoshida, Amika ;

Yamashita, Katsuhisa ;

Nakaoka, Yoshikazu .

MODERN RHEUMATOLOGY, 2023, 33 (05) :998-1006

[42] Refractory pyoderma gangrenosum in Caucasian adolescent with Takayasu arteritis and life-threatening infections [J].

Yeo, Ting Fong ;

Labbouz, Sofia ;

Lawrance, Nicholas ;

Sitaraaman, Hemalatha Bhuvanai ;

Tattersall, Rachel S. ;

Cork, Michael J. .

JEADV CLINICAL PRACTICE, 2025, 4 (01) :234-239

[43] Efficacy of Biological-Targeted Treatments in Takayasu Arteritis Multicenter, Retrospective Study of 49 Patients [J].

Mekinian, Arsene ;

Comarmond, Cloe ;

Resche-Rigon, Mathieu ;

Mirault, Tristan ;

Kahn, Jean Emmanuel ;

Lambert, Marc ;

Sibilia, Jean ;

Neel, Antoine ;

Cohen, Pascal ;

Hie, Miguel ;

Berthier, Sabine ;

Marie, Isabelle ;

Lavigne, Christian ;

Vandenhende, Marie Anne ;

Muller, Geraldine ;

Amoura, Zahir ;

Devilliers, Herve ;

Abad, Sebastien ;

Hamidou, Mohamed ;

Guillevin, Loic ;

Dhote, Robin ;

Godeau, Bertrand ;

Messas, Emmanuel ;

Cacoub, Patrice ;

Fain, Olivier ;

Saadoun, David .

CIRCULATION, 2015, 132 (18) :1693-1700

[44] Biologic treatments in Takayasu's Arteritis: A comparative study of tumor necrosis factor inhibitors and tocilizumab [J].

Alibaz-Oner, Fatma ;

Kaymaz-Tahra, Sema ;

Bayindir, Ozun ;

Yazici, Ayten ;

Ince, Burak ;

Kalkan, Kubra ;

Kanitez, Nilufer Alpay ;

Kocaer, Sinem Burcu ;

Bilge, Nazife Sule Yasar ;

Omma, Ahmet ;

Durak, Elif ;

Ilgin, Can ;

Akar, Servet ;

Kasifoglu, Timucin ;

Onen, Fatos ;

Emmungil, Hakan ;

Inanc, Murat ;

Cefle, Ayse ;

Aksu, Kenan ;

Keser, Gokhan ;

Direskeneli, Haner .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 2021, 51 (06) :1224-1229

[45] Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study [J].

Mekinian, Arsene ;

Biard, Lucie ;

Lorenzo, Dagna ;

Novikov, Pavel, I ;

Salvarani, Carlo ;

Espitia, Olivier ;

Sciascia, Savino ;

Michaud, Martin ;

Lambert, Marc ;

Hernandez-Rodriguez, Jose ;

Schleinitz, Nicolas ;

Awisat, Abid ;

Puechal, Xavier ;

Aouba, Achille ;

Pons, Helene Munoz ;

Smitienko, Ilya ;

Gaultier, Jean Baptiste ;

Edwige, Le Mouel ;

Benhamou, Ygal ;

Perlat, Antoinette ;

Jego, Patrick ;

Goulenok, Tiphaine ;

Sacre, Karim ;

Lioger, Bertrand ;

Hassold, Nolan ;

Broner, Jonathan ;

Dufrost, Virginie ;

Sene, Thomas ;

Seguier, Julie ;

Maurier, Francois ;

Berthier, Sabine ;

Belot, Alexandre ;

Frikha, Faten ;

Denis, Guillaume ;

Audemard-Verger, Alexandra ;

Kone-Paut, Isabelle ;

Humbert, Sebastien ;

Woaye-Hune, Pascal ;

Tomelleri, Alessandro ;

Baldissera, Elena Marina ;

Kuwana, Masataka ;

Logullo, Alberto ;

Mukuchyan, Vahan ;

Dellal, Azeddine ;

Gaches, Francis ;

Zeminsky, Pierre ;

Galli, Elena ;

Alvarado, Moya ;

Boiardi, Luigi ;

Francesco, Muratore .

RMD OPEN, 2023, 9 (02)

[46] Takayasu's arteritis: A case report and a brief review of the literature [J].

Manfrini, Olivia ;

Bugiardini, Raffaele .

HEART INTERNATIONAL, 2006, 2 (01) :66-71

[47] Takayasu's arteritis in pregnancy: A case report and literature review [J].

Bista, Apeksha ;

Thapa, Durga ;

Neupane, Prawesh ;

Gupta, Swati ;

Aryal, Shreyashi ;

Sharma, Jyotshna .

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2025, 169 (02) :525-528

[48] Treatment efficacy and safety of adalimumab versus tocilizumab in patients with active and severe Takayasu arteritis: an open-label study [J].

Wang, Jinghua ;

Kong, Xiufang ;

Ma, Lili ;

Ding, Zhenqi ;

Chen, Huiyong ;

Chen, Rongyi ;

Jin, Xuejuan ;

Chen, Caizhong ;

Lin, Jiang ;

Jiang, Lindi .

RHEUMATOLOGY, 2024, 63 (05) :1359-1367

[49] Tocilizumab in refractory giant cell arteritis. Monotherapy versus combined therapy with conventional immunosuppressive drugs. Observational multicenter study of 134 patients [J].

Calderon-Goercke, Monica ;

Castaneda, Santos ;

Aldasoro, Vicente ;

Villa, Ignacio ;

Moriano, Clara ;

Romero-Yuste, Susana ;

Narvaez, Javier ;

Gomez-Arango, Catalina ;

Perez-Pampin, Eva ;

Melero, Rafael ;

Becerra-Fernandez, Elena ;

Revenga, Marcelino ;

Alvarez-Rivas, Noelia ;

Galisteo, Carles ;

Sivera, Francisca ;

De Miguel, Eugenio ;

Prieto-Pena, Diana ;

Gonzalez-Gay, Miguel A. ;

Hernandez, Jose L. ;

Blanco, Ricardo .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 2021, 51 (02) :387-394

[50] The effectiveness of tocilizumab and its comparison with tumor necrosis factor alpha inhibitors for Takayasu Arteritis: A systematic review and meta-analysis [J].

Misra, Durga Prasanna ;

Singh, Kritika ;

Rathore, Upendra ;

Patro, Pallavi ;

Tomelleri, Alessandro ;

Campochiaro, Corrado ;

Agarwal, Vikas ;

Sharma, Aman .

AUTOIMMUNITY REVIEWS, 2023, 22 (03)

← 1 2 3 4 5 →